Fix A S, Horn J W, Wightman K A, Johnson C A, Long G G, Storts R W, Farber N, Wozniak D F, Olney J W
Toxicology Research Laboratories, Lilly Research Laboratories, Eli Lilly and Company, Greenfield, Indiana 46140.
Exp Neurol. 1993 Oct;123(2):204-15. doi: 10.1006/exnr.1993.1153.
MK(+)801 (dizocilpine maleate) is a noncompetitive antagonist at the N-methyl-D-aspartate (NMDA) receptor, the major glutamate receptor at excitatory synapses in the central nervous system. Since NMDA antagonists are neuroprotective, there is interest in their development for treatment of cerebral ischemia. Unfortunately, many of these compounds also induce vacuole formation in neurons of the rat retrosplenial cortex (Olney et al., Science 244: 1360-1362, 1989). Although vacuolization was initially reported to be reversible with MK(+)801, preliminary data later suggested that higher doses might produce neuronal necrosis. To explore this issue, young male Sprague-Dawley rats were given a single subcutaneous dose of vehicle or 1, 5, or 10 mg/kg MK(+)801. At 4 h and 1, 2, 3, 4, 7, and 14 days postdose (DPD), the retrosplenial cortex was examined by light and electron microscopy. At 4 h, vacuoles occurred in neurons of retrosplenial cortical layers 3 and 4 in all rats given MK(+)801. Mitochondria and endoplasmic reticulum contributed to vacuole formation. At 1 DPD, vacuoles or necrotic neurons were rarely observed. At all subsequent time points, necrotic neurons were readily evident in rats given 5 or 10 mg/kg MK(+)801, but only rarely evident in rats given 1 mg/kg. Necrotic neurons were associated with reactive microglial cells that contained electron-dense debris ultrastructurally. If similar dose-dependent neuronal necrosis proves to be a feature of other NMDA antagonists, such effects might raise concerns for the development and use of these compounds in human cerebrovascular diseases.
MK(+)801(马来酸二氮卓西平)是N-甲基-D-天冬氨酸(NMDA)受体的非竞争性拮抗剂,NMDA受体是中枢神经系统兴奋性突触中的主要谷氨酸受体。由于NMDA拮抗剂具有神经保护作用,人们对其用于治疗脑缺血的开发很感兴趣。不幸的是,这些化合物中的许多还会在大鼠脾后皮质的神经元中诱导液泡形成(奥尔尼等人,《科学》244:1360 - 1362,1989)。尽管最初报道液泡化在MK(+)801作用下是可逆的,但后来的初步数据表明,更高剂量可能会导致神经元坏死。为了探究这个问题,给年轻雄性斯普拉格 - 道利大鼠皮下注射单次剂量的赋形剂或1、5或10mg/kg的MK(+)801。在给药后4小时以及1、2、3、4、7和14天,通过光镜和电镜检查脾后皮质。给药后4小时,所有给予MK(+)801的大鼠的脾后皮质第3和第4层神经元中出现液泡。线粒体和内质网参与了液泡形成。给药后1天,很少观察到液泡或坏死神经元。在所有后续时间点,给予5或10mg/kg MK(+)801的大鼠中坏死神经元很明显,但给予1mg/kg的大鼠中很少见。坏死神经元与反应性小胶质细胞相关,这些小胶质细胞在超微结构上含有电子致密碎片。如果类似的剂量依赖性神经元坏死被证明是其他NMDA拮抗剂的一个特征,那么这些效应可能会引发对这些化合物在人类脑血管疾病中的开发和使用的担忧。